23andMe to share customer gene data with GlaxoSmithKline for $300M

Re:23andMe to share customer gene data with GlaxoSmithKline ... by dekhn on Wednesday December 18, 2019 @10:46AM (#21826000)

The problem is you gave a single anecdotal example, and there was a bunch of attention paid at the time anyway and lots of people complained.

You can't insert major changes to health laws in omnibus spending bills.

[ Parent | on HN ]

Re:23andMe to share customer gene data with GlaxoSmithKline ... by zepto on Wednesday December 18, 2019 @10:58AM (#21826146)

There is nothing anecdotal about it, since it is a fact.

Almost nobody complained, there was no meaningful mainstream coverage, and most people don’t even know there was a change even now.

And you don’t need to insert a major change to punch a hole in the law. A small exception will do it.

[ Parent | on HN ]